Quality of life (QoL) in the phase 3 METEOR trial of cabozantinib vs everolimus for advanced renal cell carcinoma (RCC) Meeting Abstract
| Authors: | Cella, D.; Escudier, B.; Tannir, N.; Powles, T.; Donskov, F.; Peltola, K.; Schmidinger, M.; Heng, D.; Mainwaring, P.; Hammers, H.; Lee, J. L.; Rini, B. I.; Roth, B.; Baer, J.; Mangeshkar, M.; Scheffold, C.; Hutson, T.; Pal, S.; Motzer, R. J.; Choueiri, T. K. |
| Abstract Title: | Quality of life (QoL) in the phase 3 METEOR trial of cabozantinib vs everolimus for advanced renal cell carcinoma (RCC) |
| Meeting Title: | 41st European Society for Medical Oncology Congress (ESMO) |
| Journal Title: | Annals of Oncology |
| Volume: | 27 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2016 Oct 7-11 |
| Meeting Location: | Copenhagen, Denmark |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2016-10-01 |
| Start Page: | vi284 |
| Language: | English |
| ACCESSION: | WOS:000393912500811 |
| DOI: | 10.1093/annonc/mdw373.43 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 816P -- Source: Wos |
